Acorn Biolabs
Toronto
About Acorn Biolabs
Acorn Biolabs is a healthcare technology company that provides access to the future of cell-based medicine through a non-invasive, follicle-based cell collection and cryopreservation service. Acorn Biolabs is cryopreserving people's healthy young cells for use in future regenerative treatments. Acorn Biolabs' services are available to consumers directly through at-home and in-clinic collections and are available across Canada through a network of clinic and pharmacy partners.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2024)
- Website: acorn.me
- Phone: [email protected]
Industries & Categories
Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/acorn-biolabs-74099 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.